Investor overview · November 13, 2026

RepVector traction

Verified product progress. Transparent evidence. A practical intelligence workflow for healthcare field teams.

Verified operating snapshot
3,236,045
Source rows in completed preset imports

Includes drug and billing-code cohorts; not unique providers.

27
Completed national drug cohorts

Plus 17 completed billing-code cohorts.

50
States verified for three new drug cohorts

Sertraline, lovastatin and sacubitril.

Source: RepVector completed-import records and geography checks, November 13, 2026; underlying CMS reporting year 2024. These are dated operating metrics, not customer adoption or revenue. Remaining cohorts are unfinished; not every drug or city is fully covered.

Commercial traction

Customer counts, monthly recurring revenue, retention and measured customer outcomes have not been supplied for publication. We do not present internal testing, data volume or pricing as evidence of sales.

Customer numbers: not publishedRevenue: not publishedCustomer ROI: not verified

Documented product examples

Case studies from our own verification

Internal product checks—not customer endorsements, clinical outcomes or measured ROI.

Sertraline prescribing near Austin

The question
Which Medicare providers near Austin have published sertraline activity?
Verified result
1,048 providers within a 25-mile city-centre radius, returned with a real scored preview after completing 237,719 national source rows.
What it does not prove
Current commercial prescribing, referrals or exact practice-to-practice driving distance.

Browser-verified November 13, 2026 · CMS Part D 2024

From a saved list to a field route

The workflow
Reopen a saved provider list, choose stops and generate a route sheet.
Verified result
An internal 40-provider list exported with score/source evidence; a 25-stop Google route and printable route sheet were checked on desktop and mobile.
What it does not prove
Customer adoption, time saved, lower mileage or increased revenue. Route estimates are not live-traffic guarantees.

Internal account verification · November 2026

Investor contact

Start a conversation

Request a product discussion, ask about the evidence, or tell us your investment focus.

Your details are shared privately with the RepVector team. Please do not include patient information or confidential investment documents.